California Post Acute: Medication Alert Failures - CA
The failure violated the facility's own policies and left the resident without proper medical evaluation during a period when she should have been monitored closely for adverse drug reactions.
Federal inspectors discovered the medication oversight during an August complaint investigation at the Los Angeles nursing home. The inspection revealed that multiple staff members recognized the resident needed medical attention but failed to act.
Resident 1 received Quetiapine throughout July 2025, according to her medication administration record reviewed by inspectors. The antipsychotic drug, commonly prescribed for behavioral symptoms in dementia patients, can cause serious side effects including sedation, falls, and metabolic complications.
When the resident began experiencing continuous adverse reactions to the medication, nursing staff documented the problems but took no further action. The facility's registered nurse supervisor, identified as RNS 1, told inspectors that the resident's physician should have been notified immediately when the side effects began.
"Resident 1's physician should have been notified when Resident 1 experienced continuous side effects from Quetiapine because the physician would order to hold the Quetiapine," RNS 1 stated during the August 11 inspection interview.
The supervisor also acknowledged that staff should have initiated a "change of condition" protocol for the resident, a formal process designed to ensure rapid medical response when patients experience health deteriorations.
California Post Acute's own policies required exactly this type of notification. The facility's "Notification of Changes" policy, dated November 2017, explicitly states that staff must notify physicians and resident representatives of significant changes in a resident's physical, mental, or psychosocial status.
The policy specifically mentions "deterioration in health, mental, or psychosocial status in either life-threatening conditions or clinical complications" as situations requiring immediate physician contact.
The director of nursing confirmed the policy violations during her interview with inspectors on August 11. She agreed that the resident's physician should have been contacted when the continuous side effects began.
More concerning, the director of nursing stated that based on the medication administration record documentation, "Resident 1 should be sent to the hospital for evaluation." However, she noted the resident "has been okay and not showing any signs of distress" at the time of the inspection.
The director's acknowledgment that the resident warranted hospital evaluation underscored the seriousness of the medication reaction that staff had allowed to continue without medical intervention.
Quetiapine belongs to a class of drugs that federal regulators have identified as particularly dangerous for elderly nursing home residents. The facility's own policy on psychoactive medications, updated as recently as January 2025, emphasizes the need for careful monitoring.
The policy states that "licensed staff and interdisciplinary team monitor residents for adverse consequences related to use of antipsychotic medications to reduce the potential for functional decline, hospitalization, permanent injury, and death."
Despite this clear directive, staff failed to provide the monitoring that could have prevented the resident's prolonged exposure to harmful side effects.
The medication administration record from July showed a pattern of continued Quetiapine doses even as the resident experienced ongoing adverse reactions. Each day that passed without physician notification represented another missed opportunity to adjust or discontinue the problematic medication.
Nursing staff had multiple shifts to recognize and respond to the situation. The inspection narrative references coverage across all three daily shifts – 7 a.m. to 3 p.m., 3 p.m. to 11 p.m., and 11 p.m. to 7 a.m. – on July 16, 17, and 18.
Yet none of the nursing staff during these shifts initiated contact with the resident's physician or triggered the facility's change of condition protocols.
When inspectors interviewed Resident 1 on August 11, she stated she had no complaints about the facility or staff. "They take care of me," she told inspectors during the 8:26 a.m. interview.
The resident's positive assessment of her care highlighted a troubling aspect of the violation – patients may not always recognize when they're receiving inadequate medical attention, particularly when cognitive impairments affect their judgment.
Her satisfaction with the facility's care did not negate the serious medication management failures that put her health at risk during the July incident.
The inspection classified the violation as causing "minimal harm or potential for actual harm" affecting "few" residents. However, the classification system doesn't capture the full scope of what could have happened if the resident's condition had deteriorated further without medical intervention.
Antipsychotic medications like Quetiapine can cause severe complications in elderly patients, including cardiac arrhythmias, stroke, and sudden death. The facility's failure to respond to continuous side effects represented a significant breakdown in basic medication safety protocols.
The violation occurred despite the facility having updated its psychoactive medication policy just months before the incident. The January 2025 policy revision demonstrated that administrators were aware of the risks associated with these drugs and the need for vigilant monitoring.
California Post Acute's medication management failure reflects broader challenges in nursing home care, where staff shortages and competing priorities can lead to delayed responses to resident health changes.
The resident's experience illustrates how policy compliance failures can have real consequences for vulnerable patients, even when those patients express satisfaction with their overall care.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for California Post Acute from 2025-08-11 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
CALIFORNIA POST ACUTE in LOS ANGELES, CA was cited for violations during a health inspection on August 11, 2025.
Federal inspectors discovered the medication oversight during an August complaint investigation at the Los Angeles nursing home.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.